International Journal of Head and Neck Surgery

Register      Login

VOLUME 8 , ISSUE 2 ( April-June, 2017 ) > List of Articles


Proton Therapy in the Treatment of Head and Neck Cancer

Evangelia Katsoulakis, Natalya Chernichenko, David Schreiber

Citation Information : Katsoulakis E, Chernichenko N, Schreiber D. Proton Therapy in the Treatment of Head and Neck Cancer. Int J Head Neck Surg 2017; 8 (2):45-48.

DOI: 10.5005/jp-journals-10001-1305

License: CC BY 3.0

Published Online: 01-12-2012

Copyright Statement:  Copyright © 2017; The Author(s).



To examine the value of proton therapy in relation to other treatment modalities in head and neck cancer.


Proton therapy has evolved into more sophisticated and costly intensity-modulated proton therapy and has resulted in even greater dose reduction to normal critical structures at risk as compared with photon therapy. Early clinical studies in head and neck cancers, especially for tumors of the skull base and paranasal sinuses, suggest that proton therapy is excellent in terms of local control and is comparable to intensity-modulated radiation therapy photons but with lower rates of morbidity.


There are many potential advantages to radiation therapy with protons. While there are many single institution studies examining the added value of protons to photon therapy, the value of proton therapy must be examined in prospective randomized clinical studies and across many subsites of head and neck cancer. Additional evidence is necessary to guide efficient clinical practice, patient selection, and tumors that are most likely to benefit from this treatment modality and justify proton therapy use given its significant cost.

How to cite this article

Katsoulakis E, Chernichenko N, Schreiber D. Proton Therapy in the Treatment of Head and Neck Cancer. Int J Head Neck Surg 2017;8(2):45-48.

  1. Promise and pitfalls of heavy-particle therapy. J Clin Oncol 2014 Sep;32(26):2855-2863.
  2. Establishing evidence-based indications for proton therapy: an overview of current clinical trials. Int J Radiat Oncol Biol Phys 2017 Feb;97(2):228-235.
  3. Proton therapy for head and neck cancer. Curr Opin Oncol 2015 May;27(3):165-171.
  4. The potential of intensity-modulated proton radiotherapy to reduce swallowing dysfunction in the treatment of head and neck cancer: a planning comparative study. Acta Oncol 2013 Apr;52(3):561-569.
  5. Can protons or altered fractionation decrease neurotoxicity after chemoradiation in head and neck cancer? Clin Oncol (R Coll Radiol) 2014 Dec;26(12):762-764.
  6. Spot-scanning beam proton therapy vs intensity-modulated radiation therapy for ipsilateral head and neck malignancies: a treatment planning comparison. Med Dosim 2013 Winter;38(4):390-394.
  7. Proton beam radiation therapy results in significantly reduced toxicity compared with intensity-modulated radiation therapy for head and neck tumors that require ipsilateral radiation. Radiother Oncol 2016 Feb;118(2):286-292.
  8. Clinical outcomes and patterns of disease recurrence after intensity modulated proton therapy for oropharyngeal squamous carcinoma. Int J Radiat Oncol Biol Phys 2016 May;95(1):360-367.
  9. Intensity-modulated proton beam therapy (IMPT) versus intensity-modulated photon therapy (IMRT) for patients with oropharynx cancer - a case matched analysis. Radiother Oncol 2016 Jul;120(1):48-55.
  10. Chordomas of the base of the skull and upper cervical spine. One hundred patients irradiated by a 3D conformal technique combining photon and proton beams. Acta Oncol 2005;44(7):700-708.
  11. Effectiveness and safety of spot scanning proton radiation therapy for chordomas and chondrosarcomas of the skull base: first long-term report. Int J Radiat Oncol Biol Phys 2009 Nov;75(4):1111-1118.
  12. Extent of surgery in the management of locally advanced sinonasal malignancies. Head Neck 2008 Feb;30(2):222-229.
  13. Proton radiation therapy for primary sphenoid sinus malignancies: treatment outcome and prognostic factors. Head Neck 2009 Oct;31(10):1297-1308.
  14. Charged particle therapy versus photon therapy for paranasal sinus and nasal cavity malignant diseases: a systematic review and meta-analysis. Lancet Oncol 2014 Aug;15(9):1027-1038.
  15. Proton beam reirradiation for recurrent head and neck cancer: multi-institutional report on feasibility and early outcomes. Int J Radiat Oncol Biol Phys 2016 May;95(1):386-395.
  16. Salvage re-irradiation for recurrent head and neck cancer. Int J Radiat Oncol Biol Phys 2007 Jul;68(3):731-740.
  17. Efficacy and toxicity of reirradiation using intensity-modulated radiotherapy for recurrent or second primary head and neck cancer. Cancer 2010 Oct;116(20):4761-4768.
  18. The management of head and neck tumors with high technology radiation therapy. Expert Rev Anticancer Ther 2016;16(1):99-110.
  19. Bayesian randomized trial comparing intensity modulated radiation therapy versus passively scattered proton therapy for locally advanced non-small cell lung cancer. J Clin Oncol 2016;119:S65.
  20. Proton versus intensity-modulated radiotherapy for prostate cancer: patterns of care and early toxicity. J Natl Cancer Inst 2013 Jan;105(1):25-32.
  21. AHRQ comparative effectiveness technical briefs. In: Particle beam radiation therapies for cancer. Rockville (MD): Agency for Healthcare Research and Quality (US); 2009.
  22. Research prioritization topic briefs: Topic 13. Chapel Hill: PCORI; 2017 [cited 2017]. Available from:
  23. How much are Americans willing to pay for a quality-adjusted life year? Med Care 2008 Apr;46(4):343-345.
  24. Reference pricing with evidence development: a way forward for proton therapy. J Clin Oncol 2014 May;32(15):1540-1542.
  25. An evidence based review of proton beam therapy: the report of ASTRO's emerging technology committee. Radiother Oncol 2012 Apr;103(1):8-11.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.